Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
A paper on line in the journal Radiology offers some of the earliest, formally published data from a major academic medical center on the clinical use of focal laser ablation in the treatment of low-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: focal, laser, low risk, MR-guided, therapy | 2 Comments »
In October last year, the US Food and Drug Administration approved the ExAblate MRI-guided focused ultrasound technology for the treatment of pain associated with cancer metastasis to bones, which is obviously a potential benefit for men with late stage, metastatic prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ExAblate, focal, low risk, MRi-guided, Treatment, ultrasound | 24 Comments »
A new article (available in full text) discusses the hypothetical potential of focal therapy as a form of treatment that “bridges the gap” between active surveillance and whole gland surgery or whole gland ablation for men with small amounts of early stage cancer that is entirely confined to their prostates. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, focal, outcome, potential, therapy | 2 Comments »
Many readers may be interested in two expert interviews on the OncologySTAT web site with Dr. Mark Emberton (a member of the Scientific Advisory Board of The “New “Prostate Cancer InfoLink). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: early, focal, stage, therapy | 1 Comment »
In the UK, the National Institute for Clinical Excellence (NICE) has just published guidance on the use of focal forms of high-intensity focused ultrasound (HIFU) for the treatment of (low- and intermediate-risk forms of) localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: focal, guidance, HIFU, high-intensity focused ultrasound, NICE | 5 Comments »
A report just published on line in The Lancet Oncology provides data from a study of the use of focally directed (as opposed to whole gland) high-intensity focused ultrasound (HIFU) in the treatment of a small series of men with localized prostate cancer between 2007 and 2010. The data are interesting but follow-up to date is short. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: focal, focused, HIFU, high-intensity, localized, therapy, ultrasound | 16 Comments »
A new paper in BJU International offers an analysis of data on the effectiveness and safety of focal cryotherapy (partial cryoablation of the prostate) as a first-line treatment for localized prostate cancer from the national Cryo On-Line Database (COLD) registry collected between 1997 and 2007. … READ MORE …
Filed under: Management, Treatment | Tagged: COLD registry, cryotherapy, focal, outcome | Leave a Comment »
The potential of high-intensity focused ultrasound (HIFU) as a form of focal therapy for treatment of cancer isolated to a portion of the prostate as opposed to treatment of the entire prostate has been recognized for a considerable period of time. However, limited data are available so far on the outcomes of men treated with focal HIFU. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: complication, focal, HIFU, high-intensity focused ultrasound, outcome, recurrence | 5 Comments »
In this weekend’s prostate cancer news reports, we have addressed recent publications on:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: African American, age, biopsy, brachytherapy, diabetes, focal, hormone therapy, mortality, neoadjuvant, obesity, race, single nucleotide polymorphism, SNP, Treatment | Leave a Comment »
Today’s news reports include items on:
and other items. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: cryotherapy, decision process, focal, patient, risk, sexual function, testosterone replacement, Trelstar, TRT, UroCool™ | Leave a Comment »
A review article by Polascik et al. in this month’s issue of Oncology addresses the potential of third-generation cryosurgical technology as a method to treat localized prostate cancer by freezing only targeted areas of the gland as opposed to the entire prostate. … MORE …
Filed under: Management, Treatment | Tagged: cancer, cryosurgery, cryotherapy, focal, localized, prostate | 4 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site